NCT05294523

Rocuronium and Supramaximal Stimulation

Name: Clinical Trial NCT05294523
Creator: Taipei Medical University Hospital
Keywords: Neuromuscular Blockade, Rocuronium priming dose, procedure, clinical trial, Taiwan

Priming Dose of Rocuronium and Milliamperage Value for Supramaximal Stimulation of NeuroMuscular Transmission Monitor

Taipei Medical University Hospital·ClinicalTrials.gov·procedureRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Neuromuscular Blockade
Drug/Device/Intervention: Rocuronium priming dose
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Taipei Medical University Hospital
Location: Taipei, Taiwan

Timeline & enrollment

Phase: N/A
Start date: Dec 20, 2021
End date: Dec 31, 2024
Enrollment: 300 participants

Primary outcome

Supramaximal stimulation value

Summary

To shorten induction time, some anesthesiologist gives a priming dose of muscle relaxant before starting Neuromuscular Transmission monitor (NMT). To properly evaluate neuromuscular function during the surgury, baseline supramaximal stimulation of the monitored nerve is mandatory. Not knowing if the priming dose of muscle relaxant affects the supramaximal stimulation current setting, The investigators designed this study to find out.

ICD-10 classifications

Skeletal muscle relaxants [neuromuscular blocking agents]Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents]Other neuromuscular dysfunction of bladderNeuromuscular dysfunction of bladder, unspecifiedNeuromuscular scoliosis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05294523
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05294523 through Pure Global AI's free database. This phase not specified trial is sponsored by Taipei Medical University Hospital and is currently Recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.